Cleared Traditional

K923139 - HEMOCOR HP HEMOCONCENTRATOR SERIES

K923139 is an FDA 510(k) clearance for HEMOCOR HP HEMOCONCENTRATOR SERIES, manufactured by Minntech Corp.. The device is a Class 2 Gastroenterology & Urology device with product code KDI cleared through the Traditional 510(k) pathway after a 599-day FDA review.

Download Printable Device Report (PDF) Official FDA 510(k) Summary (PDF)
Optimized for regulatory review, auditing and printing
Feb 1994
Decision
599d
Days
Class 2
Risk

K923139 is an FDA 510(k) clearance for the HEMOCOR HP HEMOCONCENTRATOR SERIES. Classified as Dialyzer, High Permeability With Or Without Sealed Dialysate System (product code KDI), Class II - Special Controls.

Submitted by Minntech Corp. (Minneapolis, US). The FDA issued a Cleared decision on February 18, 1994 after a review of 599 days - an unusually long review period, suggesting complex equivalence evaluation.

This device falls under the Gastroenterology & Urology FDA review panel, regulated under 21 CFR 876.5860 - the FDA gastroenterology and urology device framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: High-complexity regulatory submission. Elevated predicate reliance profile. The extended review timeline suggests the FDA required additional documentation before confirming substantial equivalence - a pattern common in complex or first-of-kind Gastroenterology & Urology submissions.

FDA 510(k) Submission Details - K923139

510(k) Number K923139 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received June 29, 1992
Decision Date February 18, 1994
Days to Decision 599 days
Submission Type Traditional
Review Panel Gastroenterology & Urology (GU)
Summary Summary PDF
Third-party Review No - reviewed directly by FDA
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
468d slower than avg
Panel avg: 131d · This submission: 599d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

KDI Device Classification - Class 2, Special Controls

Product Code KDI Dialyzer, High Permeability With Or Without Sealed Dialysate System
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 876.5860
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Gastroenterology & Urology devices follow this clearance model.

Regulatory Peers - KDI Dialyzer, High Permeability With Or Without Sealed Dialysate System

All 338
Devices cleared under the same product code (KDI) and FDA review panel - the closest regulatory comparables to K923139.
PRIMUS HOLLOW FIBER DIALYZER MOD. 1000, 1350, 2000
K923727 · Minntech Corp. · Jul 1994
LUNDIA ALPHA 700 HEMODIALYZER
K931720 · C.G.H. Medical, Inc. · Jul 1994
HEMOSPAL KIT B22 / MULTIFLOW 60 KIT
K924437 · C.G.H. Medical, Inc. · Jun 1994
HIGH PERMEABILITY DIALYER
K923312 · Minntech Corp. · Feb 1994
FRESENIUS POLYSULFONE DIALYZERS
K921134 · Fresenius USA, Inc. · Dec 1993
MODIFIED ASAHI PAN-SERIES HEMOFILTERS
K914020 · Asahi Medical Co., Ltd. · Mar 1992